Načítá se...
The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing α(v)β(3) integrin in chick embryo and nude mouse models
Echistatin, a cyclic RGD peptide, which is an antagonist of α(v)β(3) integrin (disintegrin), inhibited human osteosarcoma in the chick chorioallontoic membrane (CAM) model and tumor growth and pulmonary metastases in a nude mouse orthotopic model. A high-metastatic variant of human osteosarcoma, 143...
Uloženo v:
Vydáno v: | Oncotarget |
---|---|
Hlavní autoři: | , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Impact Journals LLC
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349968/ https://ncbi.nlm.nih.gov/pubmed/27894082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13497 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|